Ji L, Lu Y, Shen Z, Hu P, et al. Impact of baseline characteristics on the efficacy of once-weekly subcutaneous semaglutide among participants with type 2 diabetes: A post hoc analysis of SUSTAIN China. Diabetes Obes Metab 2024 Sep 16. doi: 10.1111/dom.15888.
PMID: 39279647